SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

19 May 2023 Evaluate
The revenue zoomed 21.97% to Rs. 1573.10 millions for the quarter ended March 2023 as compared to Rs. 1289.70 millions during the corresponding quarter last year.A slim rise of 7.82% was recorded in the Net profit for the quarter ended March 2023 to Rs. 96.23  millions  From Rs. 89.25 millions.Operating Profit saw a handsome growth to 152.70 millions from 148.99 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1573.10 1289.70 21.97 5274.86 4866.46 8.39 5274.86 4866.46 8.39
Other Income 10.37 10.29 0.78 61.15 51.97 17.66 61.15 51.97 17.66
PBIDT 152.70 148.99 2.49 573.90 520.43 10.27 573.90 520.43 10.27
Interest 0.23 -1.77 -112.99 2.18 9.61 -77.32 2.18 9.61 -77.32
PBDT 152.47 150.76 1.13 571.72 510.82 11.92 571.72 510.82 11.92
Depreciation 24.07 30.07 -19.95 97.00 119.60 -18.90 97.00 119.60 -18.90
PBT 128.40 120.69 6.39 474.72 391.22 21.34 474.72 391.22 21.34
TAX 32.17 31.44 2.32 112.91 85.61 31.89 112.91 85.61 31.89
Deferred Tax -5.93 -4.56 30.04 -8.29 -9.95 -16.68 -8.29 -9.95 -16.68
PAT 96.23 89.25 7.82 361.81 305.61 18.39 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 9.71 11.55 -15.97 10.88 10.69 1.74 10.88 10.69 1.74

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×